Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy

NCT00676650 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
873
Enrollment
INDUSTRY
Sponsor class

Stopped Study A6181120 was prematurely discontinued due to futility on 27 September 2010. No new or unexpected safety issues were identified.

Conditions

Interventions

Sponsor

Pfizer